Erschienen in:

01.03.2005 | Original Article

Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile

verfasst von: E. Zulian, P. Sartorato, S. Benedini, G. Baro, D. Armanini, F. Mantero, C. Scaroni, MD

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 3/2005